Global Small Molecule CMO/CDMO Market
Pharmaceuticals

Which Factors Will Push The Small Molecule CMO/CDMO Market To Achieve $72.9 Billion By 2029?

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The Small Molecule CMO/CDMO Market Expected To Grow In Terms Of Size?

The CMO/CDMO market for small molecules has seen a significant increase in recent years. The market, which is valued at $50.58 billion in 2024, is projected to reach $54.42 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. The expansion in the past timeframe is associated with positive governmental backing, economic solutions, escalating complexity in drug creation, industry merging and focus on essential skillsets.

There is a prediction of robust expansion for the small molecule CMO/CDMO market in the upcoming years. An expected growth to “$72.9 billion in 2029 with a compound annual growth rate (CAGR) of 7.6%” is projected. The growth during the prediction period can be credited to the upsurge in drug pipelines, the worldwide operations of pharmaceuticals, the demand for adaptable manufacturing, biopharmaceutical convergence, and the expertise in regulatory compliance. Key trends during this period are anticipated to be sustainable and eco-friendly manufacturing practices, escalating collaboration and partnerships, customised medicine and niche treatments, growth in virtual and virtual-to-reality companies, incorporation of digital technologies, and swift response manufacturing.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13733&type=smp

What Drivers Are Accelerating Expansion Of The Small Molecule CMO/CDMO Market?

The surge in the need for pharmaceuticals is projected to fuel the expansion of the small-molecule CMO/CDMO market in the future. The pharmaceutical sector, which encompasses the invention, production, and implementation of drugs and medications by both governmental and non-governmental bodies, utilizes small-molecule CMO/CDMO. This allows for the outsourcing of services such as the creation, production, and packaging of small-molecule medications, and aids pharmaceutical firms in reducing expenses, conserving time, and enhancing procedures. For example, domestic pharmaceutical industry exports rose to 9.59 billion USD (12.79 billion CAD) in 2022, an increase from 10.71 billion CAD in 2021, as reported by the Government of Canada in August 2024. Imports also saw growth, reaching 30.21 billion CAD, up from 26.63 billion CAD in 2021. Hence, the escalating demand for pharmaceuticals is prompting the growth of the small-molecule CMO/CDMO market.

What Is The Segment Breakdown Of The Small Molecule CMO/CDMO Market?

The small molecule cmo/cdmo market covered in this report is segmented –

1) By Product: Small Molecule Drug Product, Small Molecule API

2) By Stage Type: Clinical, Commercial, Preclinical

3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics

4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders

Subsegments:

1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms

2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs

How Are Global Trends Impacting The Development Of The Small Molecule CMO/CDMO Market?

Leading firms in the small-molecule CMO/CDMO market are turning their attention to groundbreaking technologies, including the cutting-edge small-molecule platform in Shanghai, to enhance their CDMO offerings. This platform signifies the pinnacle of tech advancements aimed at producing small-molecule drugs and crafting more secure, effective, and efficiently manufactured medicinal compounds. For example, in June 2023, Porton Pharma Solutions Ltd., a pharmaceutical enterprise based in China, unveiled a sophisticated small-molecule platform in Shanghai, thereby enhancing CDMO services. This platform exemplifies a comprehensive approach, blending innovative technologies and methods to propel the complete lifecycle of small molecule pharmaceuticals, providing end-to-end solutions and greater flexibility and availability, enabled by digital transformation.

Which Companies Are Contributing Significantly To The Small Molecule CMO/CDMO Market Growth?

Major companies operating in the small molecule CMO/CDMO market report are Patheon NV (Thermo Fisher Scientific), GlaxoSmithKline, Johnson Matthey PLC, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Avid Bioservices Inc., Dishman Carbogen Amcis Ltd., ProChem Inc., Metrics Contract Services

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report

Which Region Is Leading Innovation In The Small Molecule CMO/CDMO Market?

North America was the largest region in the small molecule CMO/CDMO market in 2024. The regions covered in the small molecule CMO/CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13733&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model